| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.069 | 0.04 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.091 | 0.04 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.04 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.04 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.067 | 0.05 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.086 | 0.05 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.06 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.06 |